1ELKAYAM U, AKHTER M W, SINGH H, et al. Comparison of effects on left ventricular firing pressure of intravenous nesirifide and high-dose nitroglycerin in patients with decompensated heart failure [ J ]. Am J Cardiol, 2004, 93 (2) : 237-240.
2PUBLICATION COMMflTEE FOR THE VMAC INVESTIGATORS. Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized continUed trial[J]. JAMA, 2002, 287 (12) : 1531-1540.
3ARONSON D, BURGER A J. Intravenous nesirltide ( human B-type natriuretic peptide) reduces plasma endothelin-1 levels in patients with decompertsated congestive heart failure[J]. Am J Cardiol, 2002, 90 (4): 435- 438.
4YANCY C W, SALTZBERG M T, BERKOWITZ R L, et al. Safety and feasibility of using serial infusions of nesiritide for heart failure in an outpatient setting (from the FUSION 1 trial) [J]. Am J Caniiol, 2004, 94 (5) : 595-601.
5FONAROW G C, ADHERE SCIENTIFIC ADVISORY COMMITTEE. The Acute Decompensated Heart Failure National Registry (ADHERE) : opportunities to improve care of patients hospitalized with acute decompensated heart failure[J]. Rev Cardiovasc Med, 2003, 4 (Suppl 7) : S21-S30.
6BURGER A J, ARONSON D, HORTON D P, et al. Comparison of the effects of dobutamine and neslrifide (B-type natriurefic pepfide) on venlricular ectopy in acutely decompensated ischemic versus nonischemic cardiomyopathy[J]. Am J Cardiol, 2003, 91 (11) : 1370-1372.
7MOAZAM1 N, DAM1ANO R J, BAILEY M S, et aL Nesiritide (BNP) in the management of postoperative cardiac patients [ J ]. Ann Thorac Surg, 2003, 75 (6): 1974-1976.
8BUTLER J, EMERMAN C, PEACOCK W F , et al. The efficacy and safety of B-type natriuretlc peptide (nesiritide) in patients with renal insufllciency and acutely decompensated congestive heart failure [ J ]. Nephrol Dial Transplant, 2004, 19 (2): 391-399.
9JOSEPHSON S, BARNETT P P. Nesiritide: practical approach and benefits in the outpatient setting [ J ]. J Cardiovasc Nuts, 2004, 19 ( 5 ) : 358-363.
10SILVER M A, HORTON D P, GHALI J K, et al. Effect of nesiritide versus dobutamine on short-term outcomes in the treatment of patients with acutely decompensated heart failure [ J ]. J Am Coll Cardiol, 2002, 39(5) : 798-803.
